• Consensus Rating: Reduce
  • Consensus Price Target: $20.23
  • Forecasted Upside: -1.76%
  • Number of Analysts: 11
  • Breakdown:
  • 3 Sell Ratings
  • 6 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$20.59
▼ -1.23 (-5.64%)

This chart shows the closing price for RXO by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RXO Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RXO and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RXO

Analyst Price Target is $20.23
▼ -1.76% Downside Potential
This price target is based on 11 analysts offering 12 month price targets for RXO in the last 3 months. The average price target is $20.23, with a high forecast of $27.00 and a low forecast of $16.00. The average price target represents a -1.76% upside from the last price of $20.59.

This chart shows the closing price for RXO for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 11 polled investment analysts is to reduce stock in RXO. This Reduce consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
10/20/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
1/18/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
4/18/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
7/17/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
10/15/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
1/13/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
3/13/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings
4/12/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 3 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/25/2024SusquehannaBoost TargetNegative ➝ Negative$15.00 ➝ $16.00Low
2/13/2024OppenheimerLower TargetOutperform ➝ Outperform$23.00 ➝ $22.00Low
2/9/2024SusquehannaLower TargetNegative ➝ Negative$18.00 ➝ $15.00Low
2/9/2024TD CowenBoost TargetMarket Perform$16.50 ➝ $19.50Low
2/8/2024Bank of AmericaDowngradeBuy ➝ Neutral$25.00 ➝ $22.00Low
1/10/2024Stifel NicolausBoost TargetHold ➝ Hold$20.00 ➝ $22.00Low
1/10/2024Vertical ResearchDowngradeBuy ➝ Hold$23.00Low
10/16/2023Stifel NicolausLower TargetHold ➝ Hold$19.00 ➝ $17.00Low
10/11/2023JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$17.00 ➝ $16.00Low
10/3/2023SusquehannaLower TargetNegative ➝ Negative$14.00 ➝ $13.00Low
10/2/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$20.00 ➝ $18.00Low
8/7/2023OppenheimerReiterated RatingOutperform ➝ Outperform$24.00Low
8/3/2023Morgan StanleyReiterated RatingEqual Weight ➝ Equal Weight$20.00Low
8/3/2023StephensLower TargetEqual Weight ➝ Equal Weight$23.00 ➝ $19.00Low
7/12/2023Wolfe ResearchDowngradePeer Perform ➝ Underperform$18.00Low
6/29/2023SusquehannaLower Target$20.00 ➝ $19.00Low
6/9/2023SusquehannaInitiated CoverageNeutral$20.00Low
5/24/2023BarclaysInitiated CoverageOverweight$27.00Low
4/4/2023BenchmarkInitiated CoverageHoldLow
2/27/2023CowenInitiated CoverageMarket Perform$22.00Low
2/27/2023CowenInitiated CoverageMarket Perform$22.00Low
2/9/2023The Goldman Sachs GroupBoost TargetNeutral$20.00 ➝ $22.00Low
2/9/2023UBS GroupBoost TargetNeutral$20.00 ➝ $23.00Low
2/9/2023OppenheimerBoost TargetOutperform$21.00 ➝ $24.00Low
2/8/2023StephensReiterated RatingEqual Weight$20.00Low
1/11/2023Stifel NicolausDowngradeBuy ➝ Hold$20.00 ➝ $17.00Low
1/9/2023JPMorgan Chase & Co.Initiated CoverageNeutral$19.00Low
12/20/2022Wells Fargo & CompanyInitiated CoverageEqual Weight$18.00Low
12/9/2022UBS GroupInitiated CoverageNeutral$20.00Low
12/9/2022Morgan StanleyInitiated CoverageEqual Weight$20.00Low
12/6/2022Jefferies Financial GroupInitiated CoverageBuy$25.00Low
12/5/2022Raymond JamesInitiated CoverageMarket PerformLow
11/30/2022Bank of AmericaInitiated CoverageBuy$22.00Low
11/22/2022OppenheimerInitiated CoverageOutperform$21.00Low
11/22/2022The Goldman Sachs GroupInitiated CoverageNeutral$20.00Low
11/21/2022Vertical ResearchInitiated CoverageBuy$27.00Low
11/10/2022Wolfe ResearchInitiated CoveragePeer PerformLow
11/4/2022Stifel NicolausInitiated CoverageBuy$20.00Low
11/2/2022StephensInitiated CoverageEqual WeightLow
(Data available from 4/12/2019 forward)

News Sentiment Rating

0.31 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 9 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/15/2023
  • 3 very positive mentions
  • 7 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
10/15/2023
  • 6 very positive mentions
  • 14 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/14/2023
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/14/2023
  • 6 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/13/2024
  • 11 very positive mentions
  • 18 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
2/12/2024
  • 8 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
3/13/2024
  • 6 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
4/12/2024

Current Sentiment

  • 6 very positive mentions
  • 12 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
RXO logo
RXO, Inc. provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.
Read More

Today's Range

Now: $20.59
Low: $20.37
High: $21.64

50 Day Range

MA: $21.11
Low: $19.74
High: $22.48

52 Week Range

Now: $20.59
Low: $16.94
High: $24.33

Volume

670,201 shs

Average Volume

633,388 shs

Market Capitalization

$2.42 billion

P/E Ratio

514.88

Dividend Yield

N/A

Beta

1.08

Frequently Asked Questions

What sell-side analysts currently cover shares of RXO?

The following Wall Street analysts have issued stock ratings on RXO in the last year: Bank of America Co., Barclays PLC, JPMorgan Chase & Co., Morgan Stanley, Oppenheimer Holdings Inc., Stephens, Stifel Nicolaus, Susquehanna, TD Cowen, Vertical Research, and Wolfe Research.
View the latest analyst ratings for RXO.

What is the current price target for RXO?

11 Wall Street analysts have set twelve-month price targets for RXO in the last year. Their average twelve-month price target is $20.23, suggesting a possible downside of 1.9%. Barclays PLC has the highest price target set, predicting RXO will reach $27.00 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $16.00 for RXO in the next year.
View the latest price targets for RXO.

What is the current consensus analyst rating for RXO?

RXO currently has 3 sell ratings, 6 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for RXO.

What other companies compete with RXO?

How do I contact RXO's investor relations team?

The company's listed phone number is 980-308-6058 and its investor relations email address is [email protected]. The official website for RXO is www.rxo.com. Learn More about contacing RXO investor relations.